Breast Cancer Trial, Recruiting NCT05450016 Sponsor: Tata Memorial Centre Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT05450016
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a confirmed diagnosis of primary breast cancer (either invasive or in situ, meaning cancer that has or has not spread into surrounding tissue)
  • People who have had breast-conserving surgery (such as a lumpectomy) or full breast reconstruction
  • People who have received radiation therapy to the whole breast
  • People who have already given written consent on earlier related research projects
  • People who have provided photographs of both breasts as part of prior involvement
  • People whose cancer has not spread, or has spread only to a very limited extent (oligometastatic)
  • People aged 18 years or older
  • People who have given fresh consent to participate in this study

Who may not be able to join:

  • People who had a mastectomy (full breast removal) without having the breast fully reconstructed afterwards
  • People who have had cancer in both breasts
  • People who received radiation to only part of the breast rather than the whole breast
  • Male patients
  • People with other serious health conditions that significantly limit life expectancy
  • People who are receiving a type of internal radiation treatment called a brachytherapy boost

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tabassum Wadasadwala, MD, Tata Memorial Centre

Phone: 9324445303

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tata Memorial Centre
Registry
ClinicalTrials.gov
Start date
4 October 2021
Est. completion
1 December 2025

Where this trial is recruiting

🇮🇳 India

Primary endpoints

Proportion of patients with excellent/good cosmesis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov